Literature DB >> 12798793

Consequence of parvalbumin deficiency in the mdx mouse: histological, biochemical and mechanical phenotype of a new double mutant.

J M Raymackers1, H Debaix, M Colson-Van Schoor, F De Backer, N Tajeddine, B Schwaller, P Gailly, J M Gillis.   

Abstract

We tested the hypothesis whether the mild dystrophy in mdx mice could result from the contribution of the cytosolic calcium buffer parvalbumin in maintaining a normal cytosolic [Ca2+]i, in spite of an increased passive Ca2+ influx. By crossing mdx mice with parvalbumin-deficient mice, double mutant mice, lacking both dystrophin and parvalbumin, were obtained. Though resting cytosolic [Ca2+]i and total calcium content were similar to that of mdx muscles, this new animal model presented a slightly more severe phenotype than the mdx mouse. Muscle pseudo-hypertrophy, the density of myotubes and of centronucleated fibres as well as the loss of IIB fibres were all increased in parvalbumin-deficient mdx mice. Many of these deficits were overcome in late adulthood, albeit fibrosis was clearly more pronounced than in mdx muscles. At 90 days, parvalbumin-deficient mdx mice showed higher levels of creatine phosphokinase and lower muscle strength, in vivo, than mdx mice. Isometric tension of isolated muscle was reduced, but the susceptibility to eccentric contraction was not increased. The slight aggravation of muscle dystrophy observed in mdx mice deprived of parvalbumin cannot explain the severity of the affection observed in xmd dogs and Duchenne dystrophy patients where parvalbumin is constitutively not expressed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798793     DOI: 10.1016/s0960-8966(03)00031-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

1.  Adaptive strength gains in dystrophic muscle exposed to repeated bouts of eccentric contraction.

Authors:  Jarrod A Call; Michael D Eckhoff; Kristen A Baltgalvis; Gordon L Warren; Dawn A Lowe
Journal:  J Appl Physiol (1985)       Date:  2011-09-29

2.  Parvalbumin gene transfer impairs skeletal muscle contractility in old mice.

Authors:  Kate T Murphy; Daniel J Ham; Jarrod E Church; Timur Naim; Jennifer Trieu; David A Williams; Gordon S Lynch
Journal:  Hum Gene Ther       Date:  2012-06-05       Impact factor: 5.695

3.  Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse.

Authors:  C George Carlson; Kay Bruemmer; Jenna Sesti; Casey Stefanski; Heather Curtis; Jeffrey Ucran; Jennifer Lachey; Jasbir S Seehra
Journal:  Muscle Nerve       Date:  2011-04-01       Impact factor: 3.217

4.  Impaired neuromuscular transmission and skeletal muscle fiber necrosis in mice lacking Na/Ca exchanger 3.

Authors:  Sophie Sokolow; Mario Manto; Philippe Gailly; Jordi Molgó; Clarisse Vandebrouck; Jean-Marie Vanderwinden; Andre Herchuelz; Stéphane Schurmans
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

5.  Role of TRPC1 channel in skeletal muscle function.

Authors:  Nadège Zanou; Georges Shapovalov; Magali Louis; Nicolas Tajeddine; Chiara Gallo; Monique Van Schoor; Isabelle Anguish; My Linh Cao; Olivier Schakman; Alexander Dietrich; Jean Lebacq; Urs Ruegg; Emmanuelle Roulet; Lutz Birnbaumer; Philippe Gailly
Journal:  Am J Physiol Cell Physiol       Date:  2009-10-21       Impact factor: 4.249

6.  Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.

Authors:  Giuseppe D'Antona; Lorenza Brocca; Orietta Pansarasa; Chiara Rinaldi; Rossella Tupler; Roberto Bottinelli
Journal:  J Physiol       Date:  2007-09-13       Impact factor: 5.182

7.  Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.

Authors:  Paul T Martin; Rui Xu; Louise R Rodino-Klapac; Elaine Oglesbay; Marybeth Camboni; Chrystal L Montgomery; Kim Shontz; Louis G Chicoine; K Reed Clark; Zarife Sahenk; Jerry R Mendell; Paul M L Janssen
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-24       Impact factor: 4.249

Review 8.  Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.

Authors:  Rita Wen Kaspar; Hugh D Allen; Federica Montanaro
Journal:  J Am Acad Nurse Pract       Date:  2009-05

9.  Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease.

Authors:  Venus Ameen; Lesley G Robson
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

10.  The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.

Authors:  Marta Luna-Sánchez; Elena Díaz-Casado; Emanuele Barca; Miguel Ángel Tejada; Ángeles Montilla-García; Enrique Javier Cobos; Germaine Escames; Dario Acuña-Castroviejo; Catarina M Quinzii; Luis Carlos López
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.